BioPharma Credit PLC (OTCMKTS:BOPCF) Short Interest Up 75.0% in December

BioPharma Credit PLC (OTCMKTS:BOPCF) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totaling 7 shares, a growth of 75.0% from the November 30th total of 4 shares. Based on an average trading volume of 1 shares, the days-to-cover ratio is presently 7.0 days. Based on an average trading volume of 1 shares, the days-to-cover ratio is presently 7.0 days.

BioPharma Credit Price Performance

BOPCF stock opened at $0.85 on Friday. The stock has a 50-day moving average price of $0.91 and a 200-day moving average price of $0.90. BioPharma Credit has a 1-year low of $0.78 and a 1-year high of $0.95.

BioPharma Credit Company Profile

BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.

Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.